Yield10 Bioscience Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Yield10 Bioscience Stock Forecast and Price Target
The average price target for Yield10 Bioscience's stock of $0.50 recently provided by leading analysts would represent a 85.19% upside from its last closing price if reached. This potential increase is based on a high estimate of $0.50 and a low estimate of $0.50. Even if not interested in YTEN stock, you may want to be aware of its competitors.
85.19% Upside
Yield10 Bioscience Fair Value Forecast for 2023 - 2025 - 2030
Yield10 Bioscience's Price has increased by 100.00% In the last four years, going from $0.00 to $0.00. In the next year, analysts expect Fair Value to reach $0.29 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAS Stock Forecast | BASF | Outperform |
12
|
51.07€ | Buy/Sell | 49.50€ | 9.65% |
| CTVA Stock Forecast | Corteva | Outperform |
12
|
$53.96 | Buy/Sell | $61.72 | 18.61% |
| ADM Stock Forecast | Archer-Daniels-Midland | Hold |
8
|
$61.72 | Buy/Sell | $67.70 | 3.21% |
| A097950 Stock Forecast | CJ Cheiljedang | Buy |
18
|
₩332.00k | Buy/Sell | ₩414.27k | 29.52% |
| BASF Stock Forecast | BASF India | Hold |
18
|
Rp3.61k | Buy/Sell | Rp2.76k | -4.13% |
Yield10 Bioscience Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Yield10 Bioscience's Revenue has decreased by 43.75%, going from $800.00k to $450.00k. In the next year, analysts expect Revenue to reach $2.32M – an increase of 415.56%. For the next seven years, the forecast is for Revenue to grow by 23820.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 4118 Stock Forecast | Kaneka | Outperform |
17
|
¥3.70k | Buy/Sell | ¥0.00 | 4.08% |
| CBUS Stock Forecast | Cibus | Outperform |
0
|
$15.72 | Buy/Sell | $22.00 | 59.03% |
| GROW Stock Forecast | CO2 Gro | - |
8
|
C$0.04 | Buy/Sell | C$0.00 | -100.00% |
.jpg)
Yield10 Bioscience EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Yield10 Bioscience's EBITDA has grown from $-9.29M to $-13.19M – a 41.98% increase. Next year, analysts are expecting EBITDA to reach $-15.25M – an increase of 15.62%. In 2030, professionals predict that Yield10 Bioscience's EBITDA will decrease by 350.49%, reaching $33.04M.
Yield10 Bioscience EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Yield10 Bioscience's EBIT has grown by 42.03%, rising from $-9.47M to $-13.45M. For next year, analysts predict EBIT of $-15.53M, which would mean an increase of 15.46%. By 2030, professionals believe that Yield10 Bioscience's EBIT will have decreased by 342.68%, falling to $32.64M.
Yield10 Bioscience EPS Price Prediction Forecast for 2023 - 2025 - 2030
Yield10 Bioscience's EPS has increased by 100.00% In the last four years, going from $-4.04 to $0.00. In the next year, analysts expect EPS to reach $-0.90 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)